62 related articles for article (PubMed ID: 6145429)
1. A short survey on untoward effects of fluperlapine.
Müller-Oerlinghausen B
Arzneimittelforschung; 1984; 34(1A):131-4. PubMed ID: 6145429
[TBL] [Abstract][Full Text] [Related]
2. Pharmaco-EEG studies with fluperlapine.
Matejcek M; Neff G; Tjeerdsma H; Krebs E
Arzneimittelforschung; 1984; 34(1A):114-20. PubMed ID: 6145426
[TBL] [Abstract][Full Text] [Related]
3. Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
Woggon B; Heinrich K; Küfferle B; Müller-Oerlinghausen B; Pöldinger W; Rüther E; Schied HW
Arzneimittelforschung; 1984; 34(1A):122-4. PubMed ID: 6145427
[TBL] [Abstract][Full Text] [Related]
4. Fluperlapine in 104 schizophrenic patients. Open multicenter trial.
Fischer-Cornelssen KA
Arzneimittelforschung; 1984; 34(1A):125-30. PubMed ID: 6145428
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of fluperlapine compared with clozapine.
Eichenberger E
Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
8. cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects.
Sondhi S; Castellano JM; Chong VZ; Rogoza RM; Skoblenick KJ; Dyck BA; Gabriele J; Thomas N; Ki K; Pristupa ZB; Singh AN; MacCrimmon D; Voruganti P; Foster J; Mishra RK
Pharmacogenomics J; 2006; 6(2):131-40. PubMed ID: 16402076
[TBL] [Abstract][Full Text] [Related]
9. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
Kreinin A; Epshtein S; Sheinkman A; Tell E
Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
Advokat C
Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
[TBL] [Abstract][Full Text] [Related]
11. ["Rather overweight and mentally present...". Patients evaluate clozapine].
Boitz K; Angermeyer MC; Löffler W; Müller P; Priebe S
Psychiatr Prax; 1999 Jul; 26(4):188-93. PubMed ID: 10457971
[TBL] [Abstract][Full Text] [Related]
12. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
Adler G; Grieshaber S; Faude V; Thebaldi B; Dressing H
Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790
[TBL] [Abstract][Full Text] [Related]
13. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
Dursun SM; Szemis A; Andrews H; Reveley MA
J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
[TBL] [Abstract][Full Text] [Related]
14. Optimizing clozapine treatment.
Naber D
J Clin Psychiatry; 1999; 60 Suppl 12():35-8. PubMed ID: 10372609
[TBL] [Abstract][Full Text] [Related]
15. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
Sénéchal A; Landry P; Deschamps R; Lessard M
Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
[TBL] [Abstract][Full Text] [Related]
16. EEG profile studies of clozapine in volunteers and psychiatric patients.
Fink M; Irwin P; Weinhold P
Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):184-90. PubMed ID: 379884
[TBL] [Abstract][Full Text] [Related]
17. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
18. Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB/c mice.
Cheng CY; Hong CJ; Tsai SJ
Life Sci; 2005 Mar; 76(19):2269-73. PubMed ID: 15733941
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841.
Krisch I; Bole-Vunduk B; Pepelnak M; Lavric B; Ocvirk A; Budihna MV; Sket D
J Pharmacol Exp Ther; 1994 Oct; 271(1):343-52. PubMed ID: 7965734
[TBL] [Abstract][Full Text] [Related]
20. The effect of fluperlapine in acute psychotic patients.
Dieterle D; Eben E; Einhäupl K; Hippius H; Klein H; Rüther E; Schmauss M
Pharmacopsychiatry; 1984 Mar; 17(2):57-60. PubMed ID: 6728910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
